A large cohort of 199 patients from Russia with aniridia or aniridia-related phenotypes was studied for the PAX6 mutation spectrum, considering the background of the PAX6 mutation spectrum in the world’s population and the ratio of de novo mutations in the whole genome. The gene discussed is PAX6; the disease is aniridia.